KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Tenet Healthcare (THC) over the last 14 years, with Q4 2025 value amounting to $364.0 million.

  • Tenet Healthcare's Capital Expenditures rose 1030.3% to $364.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 848.55%. This contributed to the annual value of $1.0 billion for FY2025, which is 848.55% up from last year.
  • Per Tenet Healthcare's latest filing, its Capital Expenditures stood at $364.0 million for Q4 2025, which was up 1030.3% from $280.0 million recorded in Q3 2025.
  • Tenet Healthcare's 5-year Capital Expenditures high stood at $364.0 million for Q4 2025, and its period low was $111.0 million during Q3 2021.
  • In the last 5 years, Tenet Healthcare's Capital Expenditures had a median value of $184.5 million in 2023 and averaged $205.6 million.
  • Data for Tenet Healthcare's Capital Expenditures shows a peak YoY increase of 8313.25% (in 2021) and a maximum YoY decrease of 3351.65% (in 2021) over the last 5 years.
  • Over the past 5 years, Tenet Healthcare's Capital Expenditures (Quarter) stood at $304.0 million in 2021, then dropped by 4.61% to $290.0 million in 2022, then decreased by 28.28% to $208.0 million in 2023, then surged by 58.65% to $330.0 million in 2024, then rose by 10.3% to $364.0 million in 2025.
  • Its Capital Expenditures was $364.0 million in Q4 2025, compared to $280.0 million in Q3 2025 and $193.0 million in Q2 2025.